GSK reaches endpoint in pivotal blood canc...GlaxoSmithKline plc announced belantamab mafodotin (GSK2857916) met the primary endpoint of overall response rate (ORR) in a pivotal Phase II trial in treatment-refractive multiple myeloma. more ➔
Swiss researchers report on metastasis swi... Researchers from Paul Scherrer Institute in Villingen, Switzerland, and Hoffmann La-Roche AG report in Cell they have solved the structure of a target relevant in metastasis. more ➔
Preclinical antibody stops rheumatoid arth... An antibody therapy that targets red blood cells (RBCs) unexpectedly showed anti-inflammatory effects and rapidly reversed rheumatoid arthritis and prevented lung injury in mouse models. more ➔
Nabriva receives FDA approval for novel an...Nabriva Therapeutics plc has got the go from the FDA to market its pleuromutilin antibiotic Xenleta (lefamulin), a protein synthesis blocker with new mode-of-action to treat community-acquired bacterial … more ➔
Araris Biotech AG kicks-off with CHF2.5m s... Zurich-based ADC maker Araris Biotech AG announced the closing of an oversubscribed seed financing round of CHF2.5m with Redalpine, Schroder Adveq and VI Partners contibuting. more ➔
PharmaMar moves ahead with NDA for ZepsyreThe FDA has given the go-ahead to PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line small-cell lung cancer. more ➔
Swedish researchers find new pain organResearchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. more ➔
Researchers unravel potential cancer targe...British researchers have found out what’s going wrong with chromosome segregation in some cancers. more ➔
Pharming licenses orphan drug from Novarti...Pharming NV has paid €17.9m upfront to Novartis AG for an exclusive license to CDZ173, a late stage drug for the treatment of APDS more ➔
New stem cell population may help repair t... Researchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem cells may help repair teeth in the future. more ➔
